NCT06254001View on ClinicalTrials.gov

Effectiveness of Combined Tobacco Treatment in Hospitalized Subjects

PHASE4RecruitingINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

January 15, 2024

Primary Completion Date

January 15, 2025

Study Completion Date

June 15, 2026

Conditions
Tobacco SmokingTobacco WithdrawalNicotine AddictionNicotine WithdrawalNicotine Replacement Therapy
Interventions
DRUG

Bupropion

Bupropion will be added at doses of 150 mg to 300 mg per day in addition to nicotine replacement therapy, counseling and cognitive behavioral therapy

DRUG

Nicotine replacement therapy (Nicotine patches)

Nicotine replacement therapy (Nicotine patches) plus counseling and cognitive behavioral therapy

Trial Locations (1)

14080

RECRUITING

Instituto Nacional de Enfermedades Respiratorias, Mexico City

All Listed Sponsors
lead

National Institute of Respiratory Diseases, Mexico

OTHER_GOV